Search research articles
Contact Us
Filters
Showing results (191-200 of 251) with videos related to
Page
of 26
Sort By:
Biological Psychiatry
|
December 25, 2012
Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function
Jason M Hodge, Yiming Wang, Michael Berk, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
November 29, 2019
Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial
Melanie M Ashton, Mohammadreza Mohebbi, Alyna Turner, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
March 26, 2019
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive <i>Garcinia mangostana</i>Linn. (Mangosteen) Pericarp for Schizophrenia
Alyna Turner, John J McGrath, Olivia M Dean, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 3, 2022
The role of metformin as a treatment for neuropsychiatric illness
Seetal Dodd, Luba Sominsky, Dan Siskind, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo
Alyna Turner, Andrea Baker, Olivia M Dean, et al.
Acta Psychiatrica Scandinavica
|
July 13, 2024
Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: A systematic review and network meta-analysis
Anna Giménez-Palomo, Anjli K Chamdal, Natalie Gottlieb, et al.
Acta Neuropsychiatrica
|
November 12, 2014
The impact of age at onset of bipolar I disorder on functioning and clinical presentation
Frances Biffin, Steven Tahtalian, Kate Filia, et al.
The Medical Journal of Australia
|
August 18, 2010
From neuroprogression to neuroprotection: implications for clinical care
Michael Berk, Philippe Conus, Flávio Kapczinski, et al.
Journal of Affective Disorders
|
April 13, 2015
Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder
Chiara Cristina Bortolasci, Heber Odebrecht Vargas, Sandra Odebrecht Vargas Nunes, et al.
The International Journal of Neuropsychopharmacology
|
February 23, 2018
Mechanisms Underpinning the Polypharmacy Effects of Medications in Psychiatry
Chiara C Bortolasci, Briana Spolding, Edward Callaly, et al.
Page
of 26
Search research articles
Search
Showing results (191-200 of 251) with videos related to
Sort By:
Page
of 26
Biological Psychiatry
|
December 25, 2012
Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function
Jason M Hodge, Yiming Wang, Michael Berk, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
November 29, 2019
Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial
Melanie M Ashton, Mohammadreza Mohebbi, Alyna Turner, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
March 26, 2019
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive <i>Garcinia mangostana</i>Linn. (Mangosteen) Pericarp for Schizophrenia
Alyna Turner, John J McGrath, Olivia M Dean, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 3, 2022
The role of metformin as a treatment for neuropsychiatric illness
Seetal Dodd, Luba Sominsky, Dan Siskind, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo
Alyna Turner, Andrea Baker, Olivia M Dean, et al.
Acta Psychiatrica Scandinavica
|
July 13, 2024
Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: A systematic review and network meta-analysis
Anna Giménez-Palomo, Anjli K Chamdal, Natalie Gottlieb, et al.
Acta Neuropsychiatrica
|
November 12, 2014
The impact of age at onset of bipolar I disorder on functioning and clinical presentation
Frances Biffin, Steven Tahtalian, Kate Filia, et al.
The Medical Journal of Australia
|
August 18, 2010
From neuroprogression to neuroprotection: implications for clinical care
Michael Berk, Philippe Conus, Flávio Kapczinski, et al.
Journal of Affective Disorders
|
April 13, 2015
Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder
Chiara Cristina Bortolasci, Heber Odebrecht Vargas, Sandra Odebrecht Vargas Nunes, et al.
The International Journal of Neuropsychopharmacology
|
February 23, 2018
Mechanisms Underpinning the Polypharmacy Effects of Medications in Psychiatry
Chiara C Bortolasci, Briana Spolding, Edward Callaly, et al.
Page
of 26